Bas Trietsch, chief technology officer, MIMETAS, discusses the successes he's encountered so far using organ on a chip technology in bio/pharmaceutical research.
Bas Trietsch, chief technology officer, MIMETAS, and one of the INTERPHEX Keynote speakers in the Organ on a Chip for Pharmaceutical Development session, discusses the successes his company has encountered so far using organ on a chip technology in bio/pharmaceutical research.
For more INTERPHEX 2023 video content, check this page for updates.
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.